Biocon in drug marketing deal with Pfizer
The world’s top drug maker Pfizer said that it has entered into a deal to sell drug maker Biocon Ltd’s biosimilar versions of diabetes treatment insulin.
Pharma
Dr Reddy
Dr Reddy
US FDA nod to Zydus Cadila to sale anti BP drug
Drug firm Cadila Healthcare has got approval from US health regulator to market high blood pressure treatment tablets, Losartan Potassium and Losartan Potassium and HCTZ in the American market, reports media.
Piramal in a move to reabsorb Piramal Life Sciences
Piramal Healthcare, the renowned drug maker, is planning to merge its research and development (R&D) company Piramal Life Sciences back with itself, reports media. A possibility of merging Piramal Life Sciences back to the company was discussed earlier, but any final decision on this have not been taken so far, informed sources closed to the management.
Sun gets USFDA nod for generic heart disease drug
Drug maker Sun Pharma recently said it has received a tentative approval from US health regulator to sell a generic version of Crestor tablets, used in the treatment of various heart diseases, in the American market.
Aurigene and Pcovery in pact to undertake anti-fungal drug discovery
Aurigene Discovery Technologies Ltd, a collaborative drug discovery company with a proven track record of successful partnerships with about 10 collaborators globally, has announced a drug discovery deal with Danish start-up Pcovery, which designs and develops original drugs and agrochemicals.
New one-dose malaria drug discovered
Researchers have discovered a promising new malaria drug with the potential to treat resistant strains of the deadly disease in a single dose, according to a study published recently in the journal Science.
Marck Biosciences first to develop Paracetamol IV in plastic pack
Marck Biosciences Ltd., India
Dr Reddy
Dr. Reddy
Dr Reddy
Dr Reddy
Unveiling more effective cancer treatment:
In a major breakthrough in cancer treatment, researchers in Australia are working on a new technique towards curing the disease avoiding much inevitable effects of conventional treatment such as hair loss, vomiting, and irritated mucous membrane.
Novo Nordisk launches Victoza In India
Victoza, a revolutionary new treatment for type 2 diabetes has recently launched by Novo Nordisk, one of the leading healthcare companies in diabetes care.
GSK Pharma Plans more Investments to Support Growth
Multinational drug-maker GlaxoSmithKline Pharmaceuticals Ltd expects to see increased expenses towards supporting top-line growth and related promotional efforts in the months ahead.
